We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Cystic Macular Lesions in Patients With Retinitis Pigmentosa

Anuradha Ganesh, MD, MRCOphth; George Manayath, MD, FRCS; Rana Al-Senawi, MD; Sreelatha Ok, BSc(Optom); Sana Al-Zuhaibi, MD, FRCSC
Arch Ophthalmol. 2011;129(6):805-820. doi:10.1001/archophthalmol.2011.132.
Text Size: A A A
Published online


We read with interest the article on efficacy of topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa (RP) and Usher syndrome.1 The authors report that topical dorzolamide is effective in decreasing central foveal thickness and improving visual acuity in some patients with RP and cystoid macular edema (CME). A subset of patients with RP develop cystoid maculopathy, macular cysts that can be confused with CME on ophthalmoscopy and optical coherence tomography (OCT). This phenotype has been noted in Goldmann-Favre syndrome, enhanced S cone syndrome, and clumped pigmentary retinal degeneration, all of which were associated with mutations in the NR2E3 gene.2 While optical coherence tomography is useful in documenting this maculopathy,3 this subset of retinal dystrophies also demonstrates hypersensitivity to short-wavelength light flashes on electroretinography (ERG).4 Intravenous fluorescein angiography (IVFA) establishes the cavitary nature of the maculopathy, with no hyperfluorescence seen on angiography compared with leakage seen in patients with CME and RP.5


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

9 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.